J. Matthew Singleton, Director at Viking Therapeutics, Inc. (VKTX), bought 9,500 shares at $9.82 ($93K) on 2018-05-31, disclosed to the SEC on 2018-05-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| VKTX | SELL | 2024-08-22 | $397K | — | Filing → |
| VKTX | SELL | 2024-08-19 | $1.8M | — | Filing → |
| VKTX | SELL | 2024-08-14 | $2.4M | — | Filing → |